Polivy 30 MG Injection
- RxCUI
- 2398133
- RxNorm name
- Polivy 30 MG Injection
- Display name
- Polivy 30 MG Injection
- Full name
- Polivy 30 MG Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:50
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761121 | Polivy | polatuzumab vedotin-piiq | 351(a) | Rx | 2026-08-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| POLIVY | POLATUZUMAB VEDOTIN | Genentech, Inc. | 20a16ab2-f338-4abb-9dcd-254bd949a2bc | 2026-08-24 | Warnings, Adverse reactions | 2398133 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 20a16ab2-f338-4abb-9dcd-254bd949a2bc | Polivy 30 MG Injection [PSN] · polatuzumab vedotin-piiq 30 MG Injection [Polivy] [SBD] · Polivy 30 MG Injection [SY] | 3 | 14 | These highlights do not include all the information needed to use POLIVY safely and effectively. See full prescribing information for POLIVY. POLIVY ® (polatuzumab vedotin-piiq) for injection, for intravenous use Initial U.S. Approval: 2019 | 20260324 |